Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 6
1988 26
1989 41
1990 69
1991 91
1992 123
1993 73
1994 99
1995 120
1996 106
1997 81
1998 81
1999 73
2000 69
2001 59
2002 37
2003 49
2004 46
2005 33
2006 33
2007 46
2008 36
2009 48
2010 51
2011 48
2012 42
2013 33
2014 41
2015 38
2016 29
2017 25
2018 30
2019 17
2020 17
2021 18
2022 16
2023 8
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

1,804 results

Results by year

Filters applied: . Clear all
Page 1
Zidovudine use in pregnancy and congenital malformations.
Rough K, Sun JW, Seage GR 3rd, Williams PL, Huybrechts KF, Bateman BT, Hernandez-Diaz S. Rough K, et al. AIDS. 2017 Jul 31;31(12):1733-1743. doi: 10.1097/QAD.0000000000001549. AIDS. 2017. PMID: 28537936 Free PMC article. Review.
OBJECTIVE: There is inconsistent evidence that zidovudine use during pregnancy increases overall, cardiac, and male genital malformations. ...METHODS: Using MAX data (2000-2010), we identified pregnant women with HIV treated with antiretroviral therapy (ART). Women with at …
OBJECTIVE: There is inconsistent evidence that zidovudine use during pregnancy increases overall, cardiac, and male genital malformat …
Competition between zidovudine-sensitive and zidovudine-resistant strains of HIV.
McLean AR, Nowak MA. McLean AR, et al. AIDS. 1992 Jan;6(1):71-9. doi: 10.1097/00002030-199201000-00009. AIDS. 1992. PMID: 1543568 Review.
OBJECTIVE: To investigate competitive interactions between zidovudine-sensitive and resistant strains of HIV within the context of host-parasite population dynamic interactions between CD4+ cells and HIV. ...METHODS: The model is analysed numerically and analytically and m …
OBJECTIVE: To investigate competitive interactions between zidovudine-sensitive and resistant strains of HIV within the context of ho …
Updates on AIDS cryptosporidiosis: a review.
Garrido Dávila JI, Ramírez Ronda CH. Garrido Dávila JI, et al. Bol Asoc Med P R. 1991 Feb;83(2):65-8. Bol Asoc Med P R. 1991. PMID: 1675056 Review.
Although no effective treatment is available yet, promising results have been related to the use of Spiramycin, Erythromycin, Somatostatin and its analogues, and zidovudine....
Although no effective treatment is available yet, promising results have been related to the use of Spiramycin, Erythromycin, Somatostatin a …
Correlation between plasma glucose and hemoglobin A1c in HIV-infected individuals receiving zidovudine and non-zidovudine containing antiretroviral therapy regimens.
Saetang T, Sriphrapradang C, Phuphuakrat A, Sungkanuparph S. Saetang T, et al. HIV Res Clin Pract. 2020 Apr-Jun;21(2-3):56-62. doi: 10.1080/25787489.2020.1766864. Epub 2020 May 20. HIV Res Clin Pract. 2020. PMID: 32431248
However, using HbA1c for glycemia estimation has some fallacies in anemic persons. Zidovudine (AZT) treatment is associated with anemia and/or increased mean corpuscular volume (MCV). ...
However, using HbA1c for glycemia estimation has some fallacies in anemic persons. Zidovudine (AZT) treatment is associated with anem …
Zidovudine-associated myopathy.
Gertner E, Thurn JR, Williams DN, Simpson M, Balfour HH Jr, Rhame F, Henry K. Gertner E, et al. Am J Med. 1989 Jun;86(6 Pt 2):814-8. doi: 10.1016/0002-9343(89)90478-6. Am J Med. 1989. PMID: 2729341 No abstract available.
Resistance, drug failure, and disease progression.
Richman DD. Richman DD. AIDS Res Hum Retroviruses. 1994 Aug;10(8):901-5. doi: 10.1089/aid.1994.10.901. AIDS Res Hum Retroviruses. 1994. PMID: 7811540 Review.
The clinical significance of the reduced in vitro susceptibility of HIV to antiretroviral agents has been difficult to elucidate for nucleoside analogs such as zidovudine. However, the virological significance of resistance to nevirapine and other HIV-1-specific reverse tr …
The clinical significance of the reduced in vitro susceptibility of HIV to antiretroviral agents has been difficult to elucidate for nucleos …
The combination of arsenic, interferon-alpha, and zidovudine restores an "immunocompetent-like" cytokine expression profile in patients with adult T-cell leukemia lymphoma.
Kchour G, Rezaee R, Farid R, Ghantous A, Rafatpanah H, Tarhini M, Kooshyar MM, El Hajj H, Berry F, Mortada M, Nasser R, Shirdel A, Dassouki Z, Ezzedine M, Rahimi H, Ghavamzadeh A, de Thé H, Hermine O, Mahmoudi M, Bazarbachi A. Kchour G, et al. Retrovirology. 2013 Aug 20;10:91. doi: 10.1186/1742-4690-10-91. Retrovirology. 2013. PMID: 23962110 Free PMC article.
BACKGROUND: HTLV-I associated adult T-cell leukemia/lymphoma (ATL) carries a dismal prognosis due to chemo-resistance and immuno-compromised micro-environment. The combination of zidovudine and interferon-alpha (IFN) significantly improved survival in ATL. Promising result …
BACKGROUND: HTLV-I associated adult T-cell leukemia/lymphoma (ATL) carries a dismal prognosis due to chemo-resistance and immuno-compromised …
Human immunodeficiency virus infection in children.
Hoernle EH, Reid TE. Hoernle EH, et al. Am J Health Syst Pharm. 1995 May 1;52(9):961-79. doi: 10.1093/ajhp/52.9.961. Am J Health Syst Pharm. 1995. PMID: 7641035 Review.
However, new research is questioning the role of zidovudine monotherapy. Didanosine is the only agent with FDA-approved labeling for use as second-line therapy in children who do not respond to or become resistant to zidovudine. ...Alternatives are available for tho …
However, new research is questioning the role of zidovudine monotherapy. Didanosine is the only agent with FDA-approved labeling for …
Pharmacotherapy of HIV dementia.
Melton ST, Kirkwood CK, Ghaemi SN. Melton ST, et al. Ann Pharmacother. 1997 Apr;31(4):457-73. doi: 10.1177/106002809703100413. Ann Pharmacother. 1997. PMID: 9101009 Review.
Sustained response to zidovudine lasts 6 months to 1 year and optimal response is achieved at higher, but less tolerated, dosages. ...CONCLUSIONS: HIV-D is a devastating complication of HIV-1 infection. Zidovudine is the therapy of choice for prevention and manageme …
Sustained response to zidovudine lasts 6 months to 1 year and optimal response is achieved at higher, but less tolerated, dosages. .. …
Anti-retroviral treatment in Nigeria: a review.
Anyiwo CE, Ifeanyichukwu M. Anyiwo CE, et al. J Infect Chemother. 2000 Dec;6(4):196-9. doi: 10.1007/s101560070002. J Infect Chemother. 2000. PMID: 11810565 Review.
This review discusses such attempts and the claims of traditional medicine practitioners, as well as pilot studies on private patients with the combination therapy of zidovudine and lamivudine, which agents were allowed into the country in the late 1990s. ...This finding w …
This review discusses such attempts and the claims of traditional medicine practitioners, as well as pilot studies on private patients with …
1,804 results